HeartBeam, Inc. $BEATW
Facts as of . Built from SEC filings and our own data. Small caps move fast; check the latest filings.
Snapshot
- Exchange
- Nasdaq Capital Market
- Sector
- Surgical & Medical Instruments & Apparatus
- Headquarters
- Santa Clara, CA
- Fiscal year end
- December 31
- Shares outstanding
- 56,349,171 [10-Q 2026-08-13]
What the company doesAI summary of filing
HeartBeam is a medical technology company that develops ambulatory cardiac monitoring solutions. Its initial product, the HeartBeam System, is an FDA-cleared, cable-free device that captures heart electrical signals in three dimensions and synthesizes them into a 12-lead ECG for arrhythmia assessment. The company generated no revenue in 2025 and is in the early commercialization stage, planning a limited market launch in early 2026 targeting concierge and preventive cardiology practices. HeartBeam makes money through sale or licensing of its devices and services, including physician portal access and on-demand cardiologist reviews, and plans to seek insurance reimbursement for broader adoption. [10-K 2026-03-12]
Financial health
| Period | Revenue | Net income | Operating cash flow | Cash | Filing |
|---|---|---|---|---|---|
| 6 months to Jun 2026 | — | −$9.74M | −$6.95M | $8.72M | [10-Q 2026-08-13] |
| FY ended Dec 2025 | — | −$21.02M | −$13.99M | $4.38M | [10-K 2026-03-12] |
| FY ended Dec 2024 | — | −$19.45M | −$14.47M | $2.38M | [10-K 2026-03-12] |
- Quarterly cash burn
- −$3.48M
- Cash runway Estimate
- ~7.5 months
Capital structure and dilution
| Date | Shares outstanding | Filing |
|---|---|---|
| 2024-11-05 | 26,665,470 | [10-Q 2024-11-07] |
| 2025-03-11 | 33,725,467 | [10-K 2025-03-13] |
| 2025-05-09 | 33,806,786 | [10-Q 2025-05-13] |
| 2025-08-11 | 34,311,589 | [10-Q 2025-08-13] |
| 2025-11-11 | 34,443,563 | [10-Q 2025-11-13] |
| 2026-03-11 | 41,087,871 | [10-K 2026-03-12] |
| 2026-05-11 | 55,506,835 | [10-Q 2026-05-13] |
| 2026-08-11 | 56,349,171 | [10-Q 2026-08-13] |
- Shelf registration
- S-3 filed 2026-02-09; declared effective 2026-03-17 [S-3 2026-02-09]
Listing status
Current status: 1 Form 8-K Item 3.01 filing(s) in the last 24 months, most recent 2026-07-02. Item 3.01 covers delisting notices, failures to meet a listing rule and listing transfers; read the filing for which one.
| Date | Event | Details | Deadline | Filing |
|---|---|---|---|---|
| 2026-07-02 | 8-K Item 3.01 | Notice of delisting or failure to satisfy a continued listing rule or standard; or transfer of listing | — | [8-K 2026-07-02] |
Who owns it
| Date | Insider | Type | Shares | Price | Filing |
|---|---|---|---|---|---|
| 2026-07-24 | Persen Kenneth Harry | grant | 105,740 | — | [4 2026-07-24] |
| 2026-07-24 | Cruickshank Tim | grant | 167,760 | — | [4 2026-07-24] |
Catalysts and calendar
| Date | Type | Title |
|---|---|---|
| 2026-08-14 | 8-K | Material agreement entered |
| 2026-08-14 | 424B5 | Prospectus or prospectus supplement |
| 2026-08-13 | 13D/A | Beneficial ownership report (5%+ holder) |
| 2026-08-13 | 10-Q | Quarterly report |
| 2026-08-06 | 8-K | Director or officer change |
| 2026-08-03 | 8-K | Shareholder vote results |
| 2026-07-02 | 8-K | Listing notice or transfer |
| 2026-06-24 | 8-K | Director or officer change; Other events |
| 2026-06-22 | 8-K | Director or officer change |
| 2026-06-18 | DEF 14A | Proxy statement |
| 2026-06-05 | PRE 14A | Proxy statement |
| 2026-05-13 | 10-Q | Quarterly report |
Alerts for $BEATW
Email me when HeartBeam, Inc. files an offering, gets a deficiency notice, or moves sharply.
Facts as of . Small caps move fast; check the latest filings.